Hims & Hers Health Stock News & Updates

[WKN: A2QMYY | Symbol: HIMS]

Hims & Hers: Telemedicine Becomes Especially Important in Winter

Hims & Hers has developed into a provider in the USA that dusts off health topics and makes them...

Hims & Hers: The telemedicine stock should be back on your radar after the recent quarterly results!

The stock of Hims & Hers marks a decisive turning point with its recent quarterly results, making...

Hims & Hers: The Deal with Novo Nordisk is Approaching

Discussions about Wegovy are back on – prospectively also regarding the oral variant. Strong...

Diagnostics, Longevity, Globalization – Hims & Hers is Planning a Major Leap Forward

Hims & Hers is expected to significantly grow in the coming years and reach over $6.5 billion in...

Hims & Hers Health expands with hormone replacement programs

Hims & Hers focuses on hormones: New menopause and testosterone programs open up billion-dollar...

Hims & Hers Benefits from Legal Tailwind in the GLP-1 Market

Hims & Hers jumps 8% – a court ruling against Eli Lilly provides relief and reduces the major...

Top 5 Revenue Rockets: These Stocks Are Growing Faster Than the Market

As important as profit is for corporate success and rising stock prices: revenue growth remains empirically...

Hims Between Novo Lawsuit Risk and CEO Stock Sale

Novo Nordisk intensifies action against suppliers of Wegovy copies. CEO sells a stock package worth...

Hims & Hers Disappoints in Revenue – Analysts Praise Earnings but Warn About GLP-1 Risks

After the release of Q2 figures, Hims & Hers' share price fell by about 11-13% in after-hours trading...